Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 5:00 AM UTC
| NCT Number | NCT05031897 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 63 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Thomas Jefferson University |
| Last Updated on CT.gov | October 30, 2025 (Oct 30, 2025) |
As of October 17, 2026: Clinical trial NCT05031897 is currently recruiting participants. This phase2 study for acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Thomas Jefferson University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05031897 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05031897 was last updated Oct 30, 2025 (October 30, 2025). HelloStudys verifies this status automatically.